Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding

Daniel R. RipollBiotechnology HPC Software Applications Institute, Telemedicine and Advanced Technology Research Center, US Army Medical Research and Materiel Command, Fort Detrick, MD, USA

Daniel A. J. MitchellUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA

Lesley C. DupuyUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA

Anders WallqvistBiotechnology HPC Software Applications Institute, Telemedicine and Advanced Technology Research Center, US Army Medical Research and Materiel Command, Fort Detrick, MD, USA

Connie SchmaljohnUS Army Medical Research Institute of Infectious Diseases, Fort Detrick, MD, USA

Sidhartha ChaudhuryBiotechnology HPC Software Applications Institute, Telemedicine and Advanced Technology Research Center, US Army Medical Research and Materiel Command, Fort Detrick, MD, USACorrespondence[email protected]

Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding

Supplemental_Material.pptx

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Combinatorial peptide-based epitope mapping from Ebola virus DNA vaccines and infections reveals residue-level determinants of antibody binding

Supplemental_Material.pptx

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date